Previous Article | Next Article 
Journal of Clinical Microbiology, February 2001, p. 551-559, Vol. 39, No. 2
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.2.551-559.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Microsatellite Typing as a New Tool for
Identification of Saccharomyces cerevisiae Strains
C.
Hennequin,1,2,*
A.
Thierry,2
G. F.
Richard,2
G.
Lecointre,3
H. V.
Nguyen,4
C.
Gaillardin,4 and
B.
Dujon2
Service de Parasitologie-Mycologie et Médecine des
Voyages, CHU Amiens, F-80054 Amiens,1
Unité de Génétique Moléculaire des
Levures, URA 2171 CNRS and UFR 927, Université Pierre et Marie
Curie, Paris, Institut Pasteur, F-75724 Paris,2
Service de Systematique Moléculaire (CNRS GDR 1005),
Laboratoire d'Ichtyologie Generale et Appliquee, Museum National
d'Histoire Naturelle, 75231 Paris Cedex 05,3
and Collection de Levures d'Intérêt
Biotechnologique, UMR 216, Microbiologie et Génétique
Moléculaire, Institut National d'Agronomie de Paris Grignon,
F-78850 Thiverval Grignon,4 France
Received 25 July 2000/Returned for modification 14 August
2000/Accepted 12 October 2000
 |
ABSTRACT |
Since Saccharomyces cerevisiae appears to be an
emerging pathogen, there is a need for a valuable molecular marker able
to distinguish among strains. In this work, we investigated the
potential value of microsatellite length polymorphism with a panel of
91 isolates, including 41 clinical isolates, 14 laboratory strains, and
28 strains with industrial relevance. Testing seven polymorphic regions
(five trinucleotide repeats and two dinucleotide repeats) in a subgroup
of 58 unrelated strains identified a total of 69 alleles (6 to 13 per
locus) giving 52 different patterns with a discriminatory power of
99.03%. We found a cluster of clinical isolates sharing their genotype
with a bakery strain, suggesting a digestive colonization following
ingestion of this strain with diet. With the exception of this cluster
of isolates and isolates collected from the same patient or from
patients treated with Saccharomyces boulardii, all clinical
isolates gave different and unique patterns. The genotypes are stable,
and the method is reproducible. The possibility to make the method
portable is of great interest for further studies using this technique.
This work shows the possibility to readily identify S. boulardii (a strain increasingly isolated from invasive
infections) using a unique and specific microsatellite allele.
 |
INTRODUCTION |
The hemiascomycetous yeast
Saccharomyces cerevisiae has been used for centuries for the
production of fermented food such as cider, wine, beer, and bread. More
recently, it has also been considered as a nutritional supplement
specially used by sportsmen. Saccharomyces boulardii, now
considered a strain of S. cerevisiae (17), is
prescribed as a biotherapeutic agent for the treatment or the
prevention of diarrhea, notably that related to Clostridium difficile or associated with enteral and parenteral nutrition (20).
It is not known if S. cerevisiae is a true commensal of the
human intestinal flora or only a transient agent of gastrointestinal colonization, possibly related to its ingestion with food. Yet over the
past several years S. cerevisiae has been identified as an
occasional human pathogen. Virulence traits have been documented both
in vitro (pseudohypha formation, growth at 42°C) and in animal models
(18). In women, S. cerevisiae is mainly
responsible for vaginitis, clinically comparable to recurrent candidal
vaginitis, which can be effectively treated by the extensive use of
azole derivatives, against which S. cerevisiae is usually
resistant (27, 30). S. cerevisiae may also be
responsible for severe disease in immunocompromised patients (1,
7) and is now considered an emerging opportunist pathogen
(12). Over the past decade, a growing number of reports on
systemic and disseminated infections due to Saccharomyces
have been published, and a recent epidemiological study showed that
S. cerevisiae was responsible for 3.6% of all fungemias
(24). It has been recently demonstrated that some of these
infections are related to S. boulardii therapy (13,
24), but the epidemiology of human Saccharomyces
infections remains poorly understood.
Thus, there is a need for molecular markers able to distinguish
strains. Despite the availability of several molecular methods, data on
S. cerevisiae typing are still limited. Moreover, some of
these methods, such as karyotyping or mitochondrial DNA polymorphism, are incompletely evaluated because of the low number of strains tested
or because of the lack of studies on stability and reproducibility (28). In addition, the discriminatory power of some
methods appears insufficient when these methods are tested alone. In a comparative study of several techniques including randomly amplified polymorphic DNA, PCR fingerprinting, and enzymatic restriction of
amplified DNA, Baleiras Couto et al. concluded that there was no single
PCR-mediated typing technique able to discriminate at the strain level
(2). More-laborious pulsed-field gel electrophoresis of
NotI-digested DNA appeared to be a valuable typing method
since it could distinguish 62 distinct patterns from 76 clinical
isolates (30). Restriction fragment length polymorphism
(RFLP) generated by EcoRI digestion of total DNA allowed the
differentiation of 41 subtypes among 60 isolates (49 clinical and 11 nonclinical) (6). Moreover, the patterns could be divided
into two genetic groups that were distinguishable by the virulence of
the strains when tested in a murine model (5).
Microsatellites are short (usually less than 10-bp) sequence repeats
which have been shown to exhibit a substantial level of polymorphism
(~10
2 to 10
5) in a number of eukaryotic
genomes (26). In humans, they have been used in paternity
tests, forensic medicine, and population structure studies. They have
been successfully applied for typing fungi such as Candida
albicans (16) and Aspergillus fumigatus (3). The complete sequence of the S. cerevisiae
genome allows the identification of these regions and thus their use
for the development of this novel molecular tool for typing. Here, we report the use of microsatellite polymorphism as a new tool for the
identification of S. cerevisiae strains. It is shown that the patterns are stable and that the method is discriminant, making it
a powerful tool for epidemiological purposes.
 |
MATERIALS AND METHODS |
Strains.
Ninety-one strains were tested including 14 laboratory strains among which was the S288c strain, which has been
completely sequenced (11), 28 strains with industrial
relevance collected in eight countries, i.e., France, Spain, Russia,
China, Taiwan, Vietnam, Japan, and the Czech Republic, seven reference
strains of unknown origin, and 41 isolates collected from 36 patients (Table 1).
These patients were either outpatients
or hospitalized in eight different institutions from three European
countries (France, Spain, and The Netherlands). Isolates were collected from routine cultures of vaginal discharges, stools, sputum,
bronchoalveolar lavages, and blood cultures. Nineteen patients (21 isolates) were receiving S. boulardii therapy when their
isolates were collected. Additionally, three isolates of S. boulardii (one reference strain and two isolates collected from
commercial preparations) were tested. Strains from closely related
species, i.e., Saccharomyces pastorianus (CLIB 176, CLIB
180, CLIB 277, CLIB 1260, and CLIB 1486), Saccharomyces
paradoxus (CLIB 97, CLIB 228, CLIB 2980, and CLIB 7400), and
Saccharomyces bayanus (CLIB 251 and CLIB 106) were also
tested. Strains were stored at
80°C in 10% glycerol until tested.
Microsatellite polymorphism. (i) DNA extraction.
DNA was
extracted according to the method previously described
(15). Briefly, yeast cells were grown overnight at 30°C
in 3 ml of YPGlu medium (1% [wt/vol] yeast extract [Difco
Laboratories, Detroit, Mich.], 1% [wt/vol] Bacto peptone [Difco
Laboratories], 2% [wt/vol] glucose). Yeast cells were pelleted and
resuspended in 200 µl of lysis buffer (50 mM Tris-HCl [pH 8], 25 mM
EDTA, 1% [vol/vol]
-mercaptoethanol, 100,000 U of Zymolyase [ICN
Pharmaceuticals, Costa Mesa, Calif.]). After 1 h at 37°C, 200 µl of a solution containing 200 mM diethanolamine, pH 9 (Sigma), 80 mM EDTA, pH 9, and 1% (wt/vol) sodium dodecyl sulfate was added and
the mixture was incubated at 65°C for 30 min followed by 5 min on
ice. A volume of 100 µl of potassium acetate, 5 M, was added at 4°C
for 45 min. After centrifugation for 5 min at 10,000 × g, the supernatant was precipitated by adding ammonium
acetate at a final concentration of 2.5 M plus 3 volumes of 100%
ethanol. DNA was pelleted by centrifugation for 10 min at 10,000 × g, rinsed with 70% ethanol, dried, and resuspended in 50 µl of Tris-EDTA buffer.
(ii) Microsatellite amplification.
Seven microsatellites
(five trinucleotide and two dinucleotide simple repeats) were selected
(Table 2). Oligonucleotide primers were
designed from the sequences of the flanking regions to obtain PCR
products ranging in size between 110 and 170 bp. Amplification was
performed with a mixture containing [
-32P]dATP (500 µCi), 500 mM KCl, 100 mM Tris-HCl (pH 8.3), 15 mM MgCl2,
0.1% gelatin, deoxyribonucleotide triphosphate (0.2 mM), forward and
reverse primers (20 pmol each), Taq polymerase (1.5 U;
Eurogentec, Seraing, Belgium), and 0.5 to 1 µg of DNA. Amplification was achieved through 30 cycles (94°C for 15 s, 55°C for 1 min, 72°C for 1 min 30 s) and a final extension step at 72°C for 10 min.
(iii) Length polymorphism analysis.
Radiolabeled PCR
fragments were electrophoresed in 7.5 M urea-12.5% (1:30)
polyacrylamide vertical gels at 90 mA for 3 h. Length
polymorphisms were evaluated by comparison with the migration of the
S288c reference strain tested in triplicate in each run.
Evaluation of the method.
To test genotype stability, DNA
from six independent subclones of S288c strain were extracted and
tested simultaneously for the seven loci. In addition, an S288c strain
was grown in a fermentor for 35 weeks (about 690 generations). Twice a
week, aliquots were collected and DNA was extracted and tested by PCR
for three loci (loci 1 to 3). Genotypes of strains 25 to 32 were
determined and compared to results of the same analysis performed 3 years ago. The reproducibility was assessed by testing the S288c strain
12 times in four separate experiments for each microsatellite. Also, S. boulardii strain UL G84F88I90 was included in each of
these experiments.
Excluding pairs of strains collected from the same patient, strains
related to S. boulardii, i.e., collected from patients taking S. boulardii therapy and from commercial
preparations, and the laboratory strains which derived from a small
panel of ancestral strains (22), we consider that 58 strains are epidemiologically unrelated. Discriminatory power was
calculated for this group using the Simpson index of diversity
where N is the number of strains tested, S
is the number of different types, and nj is the
number of strains exhibiting the j type (14).
Phylogenetic analyses.
We considered that the number of
repeats at each locus was equiprobable for each isolate. Thus, all
alleles were considered as phylogenetic markers with two character
states, i.e., present (1) and absent (0). The matrix was analyzed using
the maximum-parsimony approach (unweighted heuristic search; 100 random
stepwise addition sequences) with PAUP 4 software (29). A
strict consensus tree was drawn using the midpoint rooting option.
Statistical robustness of nodes was evaluated using bootstrap
resamplings (100 iterations). Because of computation time the "fast
stepwise addition" option was used for each replicate. The consensus
tree is given, with branch lengths obtained using the Minf optimization.
Statistical analysis.
To test the hypothesis of a nonrandom
distribution of the allelic sizes, we calculated for each locus the
chi-square value by comparison of the observed distributions to
theoretically normal distributions characterized by the same geometric
mean and standard deviation. A P value below 0.05 was
considered significant.
 |
RESULTS |
All the S. cerevisiae strains, including S. boulardii, gave 100% positive PCR results with all
microsatellites tested. In contrast, typeability, defined as the
proportion of strains that are assigned to a type, was 0 for S. bayanus and ranged between 0.25 and 0.5 for S. paradoxus and between 0 and 1 for S. pastorianus, depending on the locus tested. Each locus appeared polymorphic with 12, 13, 6, 11, 8, 6, and 13 alleles for microsatellites 1 to 7, respectively (Table 3).
For each
locus considered and each strain, the size of the microsatellite on gel
was estimated. Figure 1 gives an example
of the stability of the patterns and the discriminatory power of the
method. In some of the strains analyzed, we found two bands at a given
locus. We concluded that these strains were diploid and heterozygous
for the allele considered (Table 3). In contrast, when an isolate
exhibited only one band for all loci, no conclusion on the ploidy of
the isolate could be drawn. For different loci, allele sizes were
distributed somewhat differently (data not shown). In some cases, one
allele was predominant and smaller or larger alleles were found in the
analyzed population, demonstrating a progressive continuum for
increasing or decreasing numbers of repeats (microsatellites 2, 5, 6, and 7). In other cases, no predominant allele was observed but the
sizes were distributed among six or more categories (microsatellites 1, 3, and 4). However, none of the loci studied demonstrated what could be
considered a normal (Gaussian) distribution (P < 0.05)
(data not shown).

View larger version (48K):
[in this window]
[in a new window]
|
FIG. 1.
Denaturing polyacrylamide gel electrophoresis of
products of PCR amplification of the YKL172w microsatellite
(microsatellite 1). S. cerevisiae strains are described in
Table 1. Note that CLIB 1260 (lane 3) corresponds to an S. pastorianus strain. *, clinical isolates that were collected from
patients taking S. boulardii therapy.
|
|
A total of 69 different alleles were observed, generating 52 distinct
patterns. Pattern identity was observed for French strains used in the
agroalimentary industry: strains 54 and 55; strains 44, 45, and 47;
strains 46, 48, and 50; and strains 49, 52, and 53. Similarly, among
laboratory strains, strains 30 and 31 and 10 and 11 were
indistinguishable. The last two were indistinguishable from an
apparently non-epidemiologically related strain (strain 24).
The patterns of the 21 isolates collected from the patients receiving
S. boulardii therapy were indistinguishable. These patterns were also indistinguishable from those of the two isolates of S. boulardii collected from commercial preparations and the reference strain from the manufacturer. S. boulardii-related isolates
exhibited an allele for locus 4 that was not shared with any other
strain. Among the 19 isolates collected from 17 patients not taking
S. boulardii therapy, we found 14 unique patterns. Four
French clinical isolates gave a pattern indistinguishable from that of
a French bakery strain (strain 2). There were two pairs of clinical
isolates that could not be differentiated. In both cases, they were
isolated from the same patient (isolates 66 and 67 and 58 and 59). None of the patients not treated with S. boulardii had an isolate
with a pattern characteristic of S. boulardii.
Performance of the method.
Genomic stability of assayed
microsatellites was confirmed by analysis of six independent subclones
of the S288c strain. In addition, no change of genotype was observed
over the 690 generations collected during 35 weeks of growth in a
fermentor (see Materials and Methods). Moreover, stability was also
confirmed by comparison between experiments performed 3 years ago and
the present study. Independent PCRs run using the same DNA (strain
S288c and UL G84F88I90) and the same primers gave the same pattern,
demonstrating the total reproducibility of the technique. The
discriminatory power calculated for a sample of 58 strains considered
unrelated was 99.03%.
Phylogenetic analysis.
The phylogenetic analysis provided
1,479 equiparsimonious trees of 208 steps, with a consistency index of
0.332 and a retention index of 0.7 (Fig.
2). Four clades exhibited bootstrap
proportions over 70%: the clades comprising strains 2, 5, 7, 8, and 56 (95%); strains 58 and 59 (85%); strains 66 and 67 (99%); and strains 54 and 55 (95%). Also, it was noted that 12 of the 14 laboratory strains form a clade. Similarly, 8 (strains 34, 36, 37, 38, 39, 40, 41, and 42) out of 10 Asian isolates are members of the same clade.
Finally, 7 (strains 43 to 48 and 50) out of 11 French wine strains
showed a strong identity. However, it was not possible to distinguish a
clade comprising clinical isolates. Also, there was no difference
between strains isolated in true pathogenic conditions (isolated from
blood and cases of vaginitis) and those isolated as probably commensal
organisms (feces).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 2.
Strict consensus of the 1,479 most-parsimonious
phylogenetic trees. The phylogram is constructed using the midpoint
rooting method. Tree length, 208; consistency index, 0.332; retention
index, 0.7. Strain numbering refers to Table 1. Clinical isolates from
patients not taking S. boulardii are circled. * (boxed),
S. boulardii reference strain (1), isolates
from S. boulardii commercial preparations (90 and 91), and
isolates from patients treated with S. boulardii (69 to
89).
|
|
 |
DISCUSSION |
The increasing importance of fungi among nosocomial infections
creates a need for the development of molecular markers to investigate
the epidemiology of such infections. To be useful, these methods have
to be carefully evaluated to ascertain their performance. Using the
guidelines proposed by the European Study Group on Epidemiological
Markers (28), we find that the application of
microsatellite polymorphism to S. cerevisiae is a powerful method. The development of such molecular markers is important for a
better understanding of Saccharomyces infections. For
example, in case of relapse, the method could be used to trace
isolates, to test whether the infection is due to the persistence of
the microorganism or reinfection with a new strain. Also, since the risk of transmission of S. cerevisiae from patient to
patient has been suggested (30), it is important to
identify isolates in order to demonstrate the origin of the infection
and further apply appropriate prevention measures. This is particularly
true for S. boulardii, which is increasingly reported as
responsible for bloodstream infection and for which contamination of
catheters related to hand carriage has been hypothesized
(13). In the present work, reproducibility of the method
and stability of the genomic regions were confirmed. To our knowledge,
the level of discrimination between strains obtained with this method
has never been previously reached with other methods applied to
S. cerevisiae typing, confirming the high degree of
polymorphism of these regions among strains of S. cerevisiae. All clinical strains collected from patients not
treated with S. boulardii exhibited a distinct pattern, with
the exception of isolates collected from the same patients and a
cluster of four isolates collected from French patients that shared
their pattern with that of a commercial baker yeast. In this case it
may be postulated that the colonization of the patients results from
the use of this strain in the diet, as has already been shown in
another study (23).
Another important advantage of the method is its portability. Since all
results can be expressed as a number of repeats, computer translation
is easy, offering the opportunity to compare results from different
groups via the Internet. This is an important issue for further
comparisons of larger sets of strains isolated in very different
settings, e.g., human medicine, environmental studies, and wine
production. A similar approach involving the multilocus sequence typing
method applied to bacteria has been undertaken (8, 9).
Also it should be underlined that the technique can be used with a
nonradioactive method, as has already been done for A. fumigatus (3).
The method also appears to be specific to the S. cerevisiae
species since isolates belonging to the closely related species S. pastorianus, S. paradoxus, and S. bayanus failed to be reproducibly amplified. This must be compared
to results obtained for C. albicans (10), where
Candida krusei and Candida parapsilosis failed to be amplified. This could be due to the frequent mutations observed in
the DNA sequences flanking repeats, leading to negative PCR results
(25). The positive PCR results obtained with S. boulardii isolates strongly suggest that S. boulardii
is a strain of S. cerevisiae rather than a different
species. Until now, it has not been possible to identify S. boulardii in a routine manner. Phenotypic traits such as the lack
of galactose assimilation and the lack of alpha-glucosidase activity
are characteristics of S. boulardii (19).
However none of these traits allows a definitive identification, and
confirmation requires multiple enzymatic restrictions of mitochondrial
DNA (M. Maillé, P. V. Nguyen, S. Bertout, and J. Bastide,
Program abstr. Int. Soc. Hum. Anim. Mycol., abstr. P511, 2000).
Interestingly, even the highly discriminatory randomly amplified
polymorphis DNA method failed to differentiate between isolates of
S. cerevisiae and S. boulardii (21).
In contrast, we found that sequence (CAG)9 at locus 4 is specific for
this strain and thus constitutes a rapid alternative for an accurate identification of S. boulardii. These data allow us to
confirm that Saccharomyces fungemias diagnosed in our
patients treated with S. boulardii therapy (eight cases) are
indeed due to this particular strain. The lack of polymorphism among
S. boulardii isolates is in accordance with results obtained
with EcoRI-generated RFLP, while virulence studies with an
animal model demonstrated significant differences among isolates
(17).
Considering the small number of clinical isolates different from
S. boulardii, it was not possible to test the hypothesis of
a nonrandom distribution depending on the site of isolation. The fact
that clinical isolates did not cluster argues against the hypothesis of
common virulent traits characteristic for these isolates. This may
suggest that any thermotolerant (viability at 37°C)
Saccharomyces strain is able to transiently colonize the
human gastrointestinal tract. However, this idea conflicts with
previous reports demonstrating that virulence as tested in a murine
model is more frequent in clinical isolates and is associated with
particular patterns generated with an RFLP typing method (5,
6). The gathering of laboratory strains supports the opinion of
Mortimer, i.e., that yeast molecular biology studies were mostly
carried out on a very limited panel of strains, possibly derived from
Lindegren's original strain (22). This factor must be
taken into consideration in further medical studies.
The close relationship between most French wine strains may be due
either to the use of identical starter strains to initiate the
fermentation process or to the clonal reproduction of natural strains
originating from the same geographic area. The latter possibility is
supported by the clustering of Asian isolates. Similarly, strains of
the yeast Cryptococcus neoformans var. gatti, which have an environmental ecological niche, show geographical clustering, suggesting clonal reproduction (4).
In conclusion, the analysis of microsatellite polymorphism is a
reliable method for S. cerevisiae strain identification,
including S. boulardii, which is an increasing cause of
fungemia in hospitalized patients. The phylogenetic data obtained with
this method will be useful in further studies in the field of
population genetics.
 |
ACKNOWLEDGMENTS |
We are indebted to F. Dromer, V. Lavarde, J. Meiss, A. Paugam,
J. L. Poirot, J. Ponton, and the Bureau National Interprofessional du Cognac for providing isolates and R. Longin for his help in the
continuous fermentor cultures. T. Ancelle is thanked for advice in
statistical analysis. We thank C. Raccurt for support and interest. We
thank the members of the Unité de Génétique
Moléculaire des Levures for their fruitful comments.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Unité de
Génétique Moléculaire des Levures, URA 2171 CNRS and
UFR 927, Université Pierre et Marie Curie, Paris, Institut
Pasteur, 25 rue du Dr. Roux, 75724 Paris, France. Phone: 33-1-45-68-07. Fax: 33-1-40-61-34-56. E-mail: chennequin{at}yahoo.com.
 |
REFERENCES |
| 1.
|
Aucott, J. N.,
J. Fayen,
H. Grossnicklas,
A. Morrissey,
M. M. Lederman, and R. A. Salata.
1990.
Invasive infection with Saccharomyces cerevisiae: report of three cases and review.
Rev. Infect. Dis.
12:406-411[Medline].
|
| 2.
|
Baleiras Couto, M. M.,
B. Eijsma,
H. Hofstra,
J. H. Huis in't Veld, and J. M. van der Vossen.
1996.
Evaluation of molecular typing techniques to assign genetic diversity among Saccharomyces cerevisiae strains.
Appl. Environ. Microbiol.
62:41-46[Abstract].
|
| 3.
|
Bart-Delabesse, E.,
J. F. Humbert,
E. Delabesse, and S. Bretagne.
1998.
Microsatellite markers for typing Aspergillus fumigatus isolates.
J. Clin. Microbiol.
36:2413-2418[Abstract/Free Full Text].
|
| 4.
|
Boekhout, T.,
A. van Belkum,
A. C. Leenders,
H. A. Verbrugh,
P. Mukamurangwa,
D. Swinne, and W. A. Scheffers.
1997.
Molecular typing of Cryptococcus neoformans: taxonomic and epidemiological aspects.
Int. J. Syst. Bacteriol.
47:432-442[Abstract/Free Full Text].
|
| 5.
|
Clemons, K. V.,
J. H. McCusker,
R. W. Davis, and D. A. Stevens.
1994.
Comparative pathogenesis of clinical and nonclinical isolates of Saccharomyces cerevisiae.
J. Infect. Dis.
169:859-867[Medline].
|
| 6.
|
Clemons, K. V.,
P. Park,
J. H. McCusker,
M. J. McCullough,
R. W. Davis, and D. A. Stevens.
1997.
Application of DNA typing methods and genetic analysis to epidemiology and taxonomy of Saccharomyces isolates.
J. Clin. Microbiol.
35:1822-1828[Abstract].
|
| 7.
|
Eng, R. H.,
R. Drehmel,
S. M. Smith, and E. J. Goldstein.
1984.
Saccharomyces cerevisiae infections in man.
Sabouraudia
22:403-407[Medline].
|
| 8.
|
Enright, M. C.,
N. P. Day,
C. E. Davies,
S. J. Peacock, and B. G. Spratt.
2000.
Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus.
J. Clin. Microbiol.
38:1008-1015[Abstract/Free Full Text].
|
| 9.
|
Enright, M. C., and B. G. Spratt.
1999.
Multilocus sequence typing.
Trends Microbiol.
7:482-487[CrossRef][Medline].
|
| 10.
|
Field, D.,
L. Eggert,
D. Metzgar,
R. Rose, and C. Wills.
1996.
Use of polymorphic short and clustered coding-region microsatellites to distinguish strains of Candida albicans.
FEMS Immunol. Med. Microbiol.
15:73-79[CrossRef][Medline].
|
| 11.
|
Goffeau, A.,
R. Aert,
M. L. Agostini-Carbone,
A. Ahmed,
M. Aigle,
L. Alberghina,
K. Albermann,
M. Albers,
M. Aldea,
D. Alexandraki,
G. Aljinovic,
E. Allen,
J. Alt-Morbe,
B. Andre,
S. Andrews,
W. Ansorge,
G. Antoine,
R. Anwar,
A. Aparicio,
R. Araujo,
J. Arino,
F. Arnold,
J. Arroyo,
E. Aviles, and U. Backes.
1997.
The yeast genome directory.
Nature
387(Suppl.):1-105.
|
| 12.
|
Hazen, K.
1995.
New and emerging yeast pathogens.
Clin. Microbiol. Rev.
8:462-478[Abstract].
|
| 13.
|
Hennequin, C.,
C. Kauffmann-Lacroix,
A. Jobert,
J. P. Viard,
C. Ricour,
J. L. Jacquemin, and P. Berche.
2000.
Saccharomyces boulardii fungemia: the possible role of catheter.
Eur. J. Clin. Microbiol. Infect. Dis.
19:16-20[CrossRef][Medline].
|
| 14.
|
Hunter, P.
1990.
Reproducibility and indices of discriminatory power of microbial typing method.
J. Clin. Microbiol.
28:1903-1905[Abstract/Free Full Text].
|
| 15.
|
Johnston, J. R.,
C. R. Contopoulou, and R. K. Mortimer.
1988.
Karyotyping of yeast strains of several genera by field inversion gel electrophoresis.
Yeast
4:191-198[CrossRef][Medline].
|
| 16.
|
Lunel, F. V.,
L. Licciardello,
S. Stefani,
H. A. Verbrugh,
W. J. Melchers,
J. F. Meis,
S. Scherer, and A. van Belkum.
1998.
Lack of consistent short sequence repeat polymorphisms in genetically homologous colonizing and invasive Candida albicans strains.
J. Bacteriol.
180:3771-3778[Abstract/Free Full Text].
|
| 17.
|
McCullough, M. J.,
K. V. Clemons,
J. H. McCusker, and D. A. Stevens.
1998.
Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.).
J. Clin. Microbiol.
36:2613-2617[Abstract/Free Full Text].
|
| 18.
|
McCusker, J. H.,
K. V. Clemons,
D. A. Stevens, and R. W. Davis.
1994.
Saccharomyces cerevisiae virulence phenotype as determined with CD-1 mice is associated with the ability to grow at 42°C and form pseudohyphae.
Infect. Immun.
62:5447-5455[Abstract/Free Full Text].
|
| 19.
|
McFarland, L. V.
1996.
Saccharomyces boulardii is not Saccharomyces cerevisiae.
Clin. Infect. Dis.
22:200-201[Medline].
|
| 20.
|
McFarland, L. V., and P. Bernasconi.
1993.
Saccharomyces boulardii: a review of an innovative biotherapeutic agent.
Microb. Ecol. Health Dis.
343:171-172.
|
| 21.
|
Molnar, O.,
R. Messner,
H. Prillinger,
U. Stahl, and E. Slavikova.
1995.
Genotyping identification of Saccharomyces species using random amplified polymorphic DNA analysis.
Syst. Appl. Microbiol.
18:136-145.
|
| 22.
|
Mortimer, R.
2000.
Evolution and variation of the yeast (Saccharomyces) genome.
Genome Res.
10:403-409[Abstract/Free Full Text].
|
| 23.
|
Nyirjesy, P.,
J. A. Vazquez,
D. D. Ufberg,
J. D. Sobel,
D. A. Boikov, and H. R. Buckley.
1995.
Saccharomyces cerevisiae vaginitis: transmission from yeast used in baking.
Obstet. Gynecol.
86:326-329[Abstract].
|
| 24.
|
Piarroux, R.,
L. Millon,
K. Bardonnet,
O. Vagner, and H. Koenig.
1999.
Are live Saccharomyces yeasts harmful to patients?
Lancet
353:1851-1852[CrossRef][Medline].
|
| 25.
|
Richard, G. F., and B. Dujon.
1996.
Distribution and variability of trinucleotide repeats in the genome of the yeast Saccharomyces cerevisiae.
Gene
174:165-174[CrossRef][Medline].
|
| 26.
|
Richard, G. F.,
C. Hennequin,
A. Thierry, and B. Dujon.
1999.
Trinucleotide repeats and other microsatellites in yeasts.
Res. Microbiol.
150:589-602[Medline].
|
| 27.
|
Sobel, J. D.,
J. Vazquez,
M. Lynch,
C. Meriwether, and M. J. Zervos.
1993.
Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspects, and therapy.
Clin. Infect. Dis.
16:93-99[Medline].
|
| 28.
|
Struelens, M., and the Members of the European Study Group on Epidemiological Markers.
1996.
Consensus guidelines for appropriate use and evaluation of microbial epidemiologic typing systems.
Clin. Microbiol. Infect.
2:2-11[Medline].
|
| 29.
|
Swofford, D. I.
1999.
PAUP: phylogenetic analysis using parsimony, version 4.
Illinois Natural History Survey, Champaign, Ill.
|
| 30.
|
Zerva, L.,
R. J. Hollis, and M. A. Pfaller.
1996.
In vitro susceptibility testing and DNA typing of Saccharomyces cerevisiae clinical isolates.
J. Clin. Microbiol.
34:3031-3034[Abstract].
|
Journal of Clinical Microbiology, February 2001, p. 551-559, Vol. 39, No. 2
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.2.551-559.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Oliveira, V. A., Vicente, M. A., Fietto, L. G., de Miranda Castro, I., Coutrim, M. X., Schuller, D., Alves, H., Casal, M., de Oliveira Santos, J., Araujo, L. D., da Silva, P. H. A., Brandao, R. L.
(2008). Biochemical and Molecular Characterization of Saccharomyces cerevisiae Strains Obtained from Sugar-Cane Juice Fermentations and Their Impact in Cachaca Production. Appl. Environ. Microbiol.
74: 693-701
[Abstract]
[Full Text]
-
Grenouillet, F., Millon, L., Bart, J.-M., Roussel, S., Biot, I., Didier, E., Ong, A.-S., Piarroux, R.
(2007). Multiple-Locus Variable-Number Tandem-Repeat Analysis for Rapid Typing of Candida glabrata. J. Clin. Microbiol.
45: 3781-3784
[Abstract]
[Full Text]
-
Edwards-Ingram, L., Gitsham, P., Burton, N., Warhurst, G., Clarke, I., Hoyle, D., Oliver, S. G., Stateva, L.
(2007). Genotypic and Physiological Characterization of Saccharomyces boulardii, the Probiotic Strain of Saccharomyces cerevisiae. Appl. Environ. Microbiol.
73: 2458-2467
[Abstract]
[Full Text]
-
Matute, D. R., Sepulveda, V. E., Quesada, L. M., Goldman, G. H., Taylor, J. W., Restrepo, A., McEwen, J. G.
(2006). Microsatellite Analysis of Three Phylogenetic Species of Paracoccidioides brasiliensis.. J. Clin. Microbiol.
44: 2153-2157
[Abstract]
[Full Text]
-
Lasker, B. A., Butler, G., Lott, T. J.
(2006). Molecular Genotyping of Candida parapsilosis Group I Clinical Isolates by Analysis of Polymorphic Microsatellite Markers.. J. Clin. Microbiol.
44: 750-759
[Abstract]
[Full Text]
-
Richard, G.-F., Dujon, B.
(2006). Molecular Evolution of Minisatellites in Hemiascomycetous Yeasts. Mol Biol Evol
23: 189-202
[Abstract]
[Full Text]
-
Sampaio, P., Gusmao, L., Correia, A., Alves, C., Rodrigues, A. G., Pina-Vaz, C., Amorim, A., Pais, C.
(2005). New Microsatellite Multiplex PCR for Candida albicans Strain Typing Reveals Microevolutionary Changes. J. Clin. Microbiol.
43: 3869-3876
[Abstract]
[Full Text]
-
Malgoire, J. Y., Bertout, S., Renaud, F., Bastide, J. M., Mallie, M.
(2005). Typing of Saccharomyces cerevisiae Clinical Strains by Using Microsatellite Sequence Polymorphism. J. Clin. Microbiol.
43: 1133-1137
[Abstract]
[Full Text]
-
Nascimento, E., Martinez, R., Rodrigues Lopes, A., de Souza Bernardes, L. A., Pomponio Barco, C., Goldman, M. H. S., Taylor, J. W., McEwen, J. G., Pasetto Nobrega, M., Nobrega, F. G., Goldman, G. H.
(2004). Detection and Selection of Microsatellites in the Genome of Paracoccidioides brasiliensis as Molecular Markers for Clinical and Epidemiological Studies. J. Clin. Microbiol.
42: 5007-5014
[Abstract]
[Full Text]
-
Edwards-Ingram, L. C., Gent, M. E., Hoyle, D. C., Hayes, A., Stateva, L. I., Oliver, S. G.
(2004). Comparative Genomic Hybridization Provides New Insights Into the Molecular Taxonomy of the Saccharomyces Sensu Stricto Complex. Genome Res
14: 1043-1051
[Abstract]
[Full Text]
-
Lasker, B. A., Ran, Y.
(2004). Analysis of Polymorphic Microsatellite Markers for Typing Penicillium marneffei Isolates. J. Clin. Microbiol.
42: 1483-1490
[Abstract]
[Full Text]
-
Sampaio, P., Gusmao, L., Alves, C., Pina-Vaz, C., Amorim, A., Pais, C.
(2003). Highly Polymorphic Microsatellite for Identification of Candida albicans Strains. J. Clin. Microbiol.
41: 552-557
[Abstract]
[Full Text]
-
Sivasundar, A., Hey, J.
(2003). Population Genetics of Caenorhabditis elegans: The Paradox of Low Polymorphism in a Widespread Species. Genetics
163: 147-157
[Abstract]
[Full Text]
-
Botterel, F., Desterke, C., Costa, C., Bretagne, S.
(2001). Analysis of Microsatellite Markers of Candida albicans Used for Rapid Typing. J. Clin. Microbiol.
39: 4076-4081
[Abstract]
[Full Text]
-
Bart-Delabesse, E., Sarfati, J., Debeaupuis, J.-P., van Leeuwen, W., van Belkum, A., Bretagne, S., Latge, J.-P.
(2001). Comparison of Restriction Fragment Length Polymorphism, Microsatellite Length Polymorphism, and Random Amplification of Polymorphic DNA Analyses for Fingerprinting Aspergillus fumigatus Isolates. J. Clin. Microbiol.
39: 2683-2686
[Abstract]
[Full Text]